These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12403057)

  • 1. Lovastatin induces cell death in cardiomyocytes that is not reversible by coenzyme Q 10.
    Rabkin SW
    Pharmacol Toxicol; 2002 Jun; 90(6):343-5. PubMed ID: 12403057
    [No Abstract]   [Full Text] [Related]  

  • 2. Ubiquinone does not rescue acute myeloid leukemia cells from growth inhibition by statins.
    Burke LP; Lewis LD; Perez RP
    Leukemia; 2003 Jan; 17(1):267-8. PubMed ID: 12529692
    [No Abstract]   [Full Text] [Related]  

  • 3. Interaction of the HMG-CoA reductase inhibitor lovastatin and nitric oxide in cardiomyocyte cell death.
    Rabkin SW; Tsang MY
    Pharmacology; 2008; 82(1):74-82. PubMed ID: 18504415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme a reductase on serum lipoproteins and ubiquinone-10 levels in patients with familial hypercholesterolemia. 1981.
    Mabuchi H; Haba T; Tatami R; Miyamoto S; Sakai Y; Wakasugi T; Watanabe A; Koizumi J; Takeda R
    Atheroscler Suppl; 2004 Oct; 5(3):51-5. PubMed ID: 15531275
    [No Abstract]   [Full Text] [Related]  

  • 5. Reduction of protein synthesis and statin-induced cardiomyocyte cell death.
    Rabkin SW; Lodha P; Kong JY
    Cardiovasc Toxicol; 2007; 7(1):1-9. PubMed ID: 17646677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of atorvastatin on left ventricular diastolic function and ability of coenzyme Q10 to reverse that dysfunction.
    Silver MA; Langsjoen PH; Szabo S; Patil H; Zelinger A
    Am J Cardiol; 2004 Nov; 94(10):1306-10. PubMed ID: 15541254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of statin toxicity to human lymphocytes in tissue culture.
    Pettit FH; Harper RF; Vilaythong J; Chu T; Shive W
    Drug Metabol Drug Interact; 2003; 19(3):151-60. PubMed ID: 14682607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Care," cancer and coenzyme Q10.
    Sinatra ST
    J Am Coll Cardiol; 1999 Mar; 33(3):897-9. PubMed ID: 10080498
    [No Abstract]   [Full Text] [Related]  

  • 9. Statins and coenzyme Q10.
    Ellis CJ; Scott R
    Lancet; 2003 Mar; 361(9363):1134-5. PubMed ID: 12672343
    [No Abstract]   [Full Text] [Related]  

  • 10. [Myopathy caused by inhibitors of hydroxymethylglutaryl-coenzyme A reductase].
    Martinez-García FA; Martín-Fernández J; Moltó JM; Villaverde R; Morales A; Fernández-Barreiro A
    Rev Neurol; 1997 Jun; 25(142):869-71. PubMed ID: 9244616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of coenzyme Q10 on anoxia-induced changes in cultured adult rat cardiomyocytes.
    Yamana K; Nohara M; Kinoshita T; Tanimura A
    Kurume Med J; 1985; 32(3):163-8. PubMed ID: 3835395
    [No Abstract]   [Full Text] [Related]  

  • 12. HMG-CoA reductase inhibitors and coenzyme Q10.
    Nawarskas JJ
    Cardiol Rev; 2005; 13(2):76-9. PubMed ID: 15705257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coenzyme Q10 in statin-associated myopathy.
    Wolinsky H
    J Am Coll Cardiol; 2007 Nov; 50(19):1911; author reply 1911. PubMed ID: 17980261
    [No Abstract]   [Full Text] [Related]  

  • 14. Statins, coenzyme Q10, and cachexia: what's the link?
    Molfino A; Costelli P; Aversa Z; Baccino FM; Rossi Fanelli F; Muscaritoli M
    Am J Cardiol; 2007 Nov; 100(9):1497-8. PubMed ID: 17950821
    [No Abstract]   [Full Text] [Related]  

  • 15. Phase I study of lovastatin, an inhibitor of the mevalonate pathway, in patients with cancer.
    Thibault A; Samid D; Tompkins AC; Figg WD; Cooper MR; Hohl RJ; Trepel J; Liang B; Patronas N; Venzon DJ; Reed E; Myers CE
    Clin Cancer Res; 1996 Mar; 2(3):483-91. PubMed ID: 9816194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antioxidants decreases the intensification of low density lipoprotein in vivo peroxidation during therapy with statins.
    Lankin VZ; Tikhaze AK; Kukharchuk VV; Konovalova GG; Pisarenko OI; Kaminnyi AI; Shumaev KB; Belenkov YN
    Mol Cell Biochem; 2003 Jul; 249(1-2):129-40. PubMed ID: 12956408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of coenzyme Q10 on doxorubicin uptake and metabolism by mouse myocardial cells in culture.
    Takahashi K; Mayumi T; Kishi T
    Chem Pharm Bull (Tokyo); 1988 Apr; 36(4):1514-8. PubMed ID: 3416371
    [No Abstract]   [Full Text] [Related]  

  • 18. Coenzyme Q10 depletion: etiopathogenic or predisposing factor in statin associated myopathy?
    Chatzizisis YS; Vaklavas C; Giannoglou GD
    Am J Cardiol; 2008 Apr; 101(7):1071. PubMed ID: 18359340
    [No Abstract]   [Full Text] [Related]  

  • 19. [Do we kill our cardiac patients with statin therapy? Coenzyme Q10, what do we know?].
    Hyams DE; Roylance PJ; Krüger K; Bodd E
    Tidsskr Nor Laegeforen; 1994 Feb; 114(5):590. PubMed ID: 7748252
    [No Abstract]   [Full Text] [Related]  

  • 20. Statins and their side effects. Some evidence suggests coenzyme Q10 might help with muscle problems, but it's too early to recommend it.
    Harv Health Lett; 2005 Jun; 30(8):4. PubMed ID: 16136675
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.